CRITICS胃癌试验中淋巴结清扫的手术病理质量控制与方案依从性
该研究评估CRITICS试验中胃癌淋巴结清扫的手术病理质量与方案依从性,以清扫≥15枚淋巴结定义手术病理依从,以清扫指示淋巴结站定义手术依从。2007至2015年788例随机,636例行治愈性胃切除术。手术病理依从率72.8%(460例),从2007年55.0%升至2015年90.0%;手术依从率41.1%(256例),手术污染率59.6%(371例),中位Maruyama指数为1(范围0至136)。结论认为试验中手术质量优秀。
要点
- 手术病理依从定义为清扫≥15枚淋巴结,636例中72.8%达标。
- 手术依从率为41.1%,手术污染率为59.6%。
- 中位Maruyama指数为1(范围0至136),提示手术质量优秀。
核心结论
- CRITICS试验中手术质量优秀,中位Maruyama指数为1。
- 手术病理依从性逐年改善,可能与研究内质量保证计划和荷兰胃癌手术集中化有关。
研究设计与样本
- 多中心随机对照试验CRITICS的事后手术质量评估,2007至2015年随机788例,其中636例行治愈性胃切除术。
- 手术病理依从定义为清扫≥15枚淋巴结;手术依从定义为清扫指示淋巴结站;手术污染定义为清扫了应保留的淋巴结站。
- 分析Maruyama指数(MI,越低越好),该指数为手术质量指标且与生存强相关。
主要发现
- 手术病理依从率为72.8%(460/636),从2007年55.0%改善至2015年90.0%。
- 手术依从率为41.1%(256/636),手术污染率为59.6%(371/636)。
- 中位Maruyama指数为1(范围0至136)。
临床怎么用
- 胃癌根治术中应确保淋巴结清扫≥15枚以满足手术病理依从性。
- 可参考Maruyama指数评估手术质量,该试验中位值为1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to evaluate surgicopathological quality and protocol adherence for lymphadenectomy in the CRITICS trial. SUMMARY OF BACKGROUND DATA: Surgical quality assurance is a key element in multimodal studies for gastric cancer. In the multicenter CRITICS trial (ChemoRadiotherapy after Induction chemotherapy In Cancer of the Stomach), patients with resectable gastric cancer were randomized for preoperative chemotherapy, followed by gastrectomy with a D1+ lymphadenectomy (removal of stations 1 to 9 and 11), followed by either chemotherapy or chemoradiotherapy. METHODS: Surgicopathological compliance was defined as removal of ≥15 lymph nodes. Surgical compliance was defined as removal of the indicated lymph node stations. Surgical contamination was defined as removal of lymph node stations that should be left in situ. The Maruyama Index (MI, lower is better), which has proven to be an indicator of surgical quality and is strongly associated with survival, was analyzed. RESULTS: Between 2007 and 2015, 788 patients were randomized, of whom 636 patients underwent a gastrectomy with curative intent. Surgicopathological compliance occurred in 72.8% (n = 460) of the patients and improved from 55.0% (2007) to 90.0% (2015). Surgical compliance occurred in 41.1% (n = 256). Surgical contamination occurred in 59.6% (n = 371). Median MI was 1 (range 0 to 136). CONCLUSION: Surgical quality in the CRITICS trial was excellent, with a MI of 1. Surgicopathological compliance improved over the years. This might be explained by the quality assurance program within the study and centralization of gastric cancer surgery in the Netherlands.
引用
- Claassen YHM, de Steur WO, Hartgrink HH, et al. Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial. Ann Surg. 2018. PMID: 28817437. doi:10.1097/SLA.0000000000002444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。